RankingsPricing
  1. US-listed companies
  2. INSMED Inc
  3. Financials
  4. Cash and cash equivalents

INSMED IncINSM

Market cap
$41.6B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 2024555+15.06%
Dec 31, 2023482-55.09%
Dec 31, 20221,074+49.84%
Dec 31, 2021717+34.53%
Dec 31, 2020533+9.31%
Dec 31, 2019487-1.54%
Dec 31, 2018495+29.88%
Dec 31, 2017381+134.43%
Dec 31, 2016163-42.52%
Dec 31, 2015283+77.66%
Dec 31, 2014159+39.80%
Dec 31, 2013114+25.46%
Dec 31, 201291+511.41%
Dec 31, 201115

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)